Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2012, Article ID 642893, 7 pages
http://dx.doi.org/10.1155/2012/642893
Research Article

Effect of Domperidone on Insufficient Lactation in Puerperal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Motherisk Program, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8

Received 12 August 2011; Accepted 6 October 2011

Academic Editor: Doreen M. Matsui

Copyright © 2012 Alla Osadchy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. A. Palda, J. M. Guise, C. N. Wathen, and The Canadian Task Force on Preventive Health Care, “Interventions to promote breastfeeding: updated recommendations from the canadian task force on preventive health care,” CTFPHC Technical Report #03-6, Canadian Task Force, London, Ontario, Canada, 2003. View at Google Scholar
  2. B. Chalmers, C. Levitt, M. Heaman, B. O'Brien, R. Sauve, and J. Kaczorowski, “Breastfeeding rates and hospital breastfeeding practices in Canada: a national survey of women,” Birth, vol. 36, no. 2, pp. 122–132, 2009. View at Publisher · View at Google Scholar
  3. N. M. Hurst, “Recognizing and treating delayed or failed lactogenesis II,” Journal of Midwifery and Women's Health, vol. 52, no. 6, pp. 588–594, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Zuppa, P. Sindico, C. Orchi et al., “Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 13, no. 2, pp. 162–174, 2010. View at Google Scholar · View at Scopus
  5. M. Bunik, C. J. Chantry, C. R. Howard et al., “ABM clinical protocol #9: use of galactogogues in initiating or augmenting the rate of maternal milk secretion (First revision January 2011),” Breastfeeding Medicine, vol. 6, no. 1, pp. 41–49, 2011. View at Publisher · View at Google Scholar
  6. G. J. Hofmeyer and B. Van Iddekinge, “Domperidone and lactation,” The Lancet, vol. 1, no. 8325, p. 647, 1983. View at Google Scholar · View at Scopus
  7. G. J. Hofmeyr, B. Van Iddekinge, and J. A. Blott, “Domperidone: secretion in breast milk and effect on puerperal prolactin levels,” British Journal of Obstetrics and Gynaecology, vol. 92, no. 2, pp. 141–144, 1985. View at Google Scholar · View at Scopus
  8. O. P. Da Silva, D. C. Knoppert, M. M. Angelini, and P. A. Forret, “Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial,” Canadian Medical Association, vol. 164, no. 1, pp. 17–21, 2001. View at Google Scholar · View at Scopus
  9. P. M. Laduron and J. E. Leysen, “Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity,” Biochemical Pharmacology, vol. 28, no. 14, pp. 2161–2165, 1979. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Barone, “Domperidone: a peripherally acting dopamine2-receptor antagonist,” Annals of Pharmacotherapy, vol. 33, no. 4, pp. 429–440, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Patterson, T. Abell, R. Rothstein, K. Koch, and J. Barnett, “A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis,” American Journal of Gastroenterology, vol. 94, no. 5, pp. 1230–1234, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. E. W. X. Wan, K. Davey, M. Page-Sharp, P. E. Hartmann, K. Simmer, and K. F. Ilett, “Dose-effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk,” British Journal of Clinical Pharmacology, vol. 66, no. 2, pp. 283–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. US Food and Drug Administration, “FDA warns against women using unapproved drug, domperidone, to increase milk production,” FDA Talk Paper T04-17, June 2004, http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm173886.htm.
  14. N. Ahmad, J. Keith-Ferris, E. Gooden, and T. Abell, “Making a case for domperidone in the treatment of gastrointestinal motility disorders,” Current Opinion in Pharmacology, vol. 6, no. 6, pp. 571–576, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. G. Rocha and M. M. Barbosa, “QT interval prolongation associated with the oral use of domperidone in an infant,” Pediatric Cardiology, vol. 26, no. 5, pp. 720–723, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Djeddi, G. Kongolo, C. Lefaix, J. Mounard, and A. Léké, “Effect of domperidone on QT interval in neonates,” Journal of Pediatrics, vol. 153, no. 5, pp. 663–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. M. Ward, B. A. Bates, W. E. Benitz, D. J. Burchfield, J. C. Ring, and R. P. Walls, “The transfer of drugs and other chemicals into human milk,” Pediatrics, vol. 108, no. 3, pp. 776–789, 2001. View at Google Scholar
  18. P. O. Anderson and V. Valdés, “A critical review of pharmaceutical galactagogues,” Breastfeeding Medicine, vol. 2, no. 4, pp. 229–242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Petraglia, V. De Leo, and S. Sardelli, “Domperidone in defective and insufficient lactation,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 19, no. 5, pp. 281–287, 1985. View at Google Scholar
  20. M. L. Campbell-Yeo, A. C. Allen, K. S. Joseph et al., “Effect of domperidone on the composition of preterm human breast milk,” Pediatrics, vol. 125, no. 1, pp. e107–e114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. G. H. Guyatt, A. D. Oxman, G. E. Vist et al., “GRADE: an emerging consensus on rating quality of evidence and strength of recommendations,” British Medical Journal, vol. 336, no. 7650, pp. 924–926, 2008. View at Google Scholar
  22. D. Follmann, P. Elliott, I. Suh, and J. Cutler, “Variance imputation for overviews of clinical trials with continuous response,” Journal of Clinical Epidemiology, vol. 45, no. 7, pp. 769–773, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. K. R. Abrams, C. L. Gillies, and P. C. Lambert, “Meta-analysis of heterogeneously reported trials assessing change from baseline,” Statistics in Medicine, vol. 24, no. 24, pp. 3823–3844, 2005. View at Publisher · View at Google Scholar
  24. J. P. T. Higgins and S. Green, “Chapter 16: special topics in statistics,” in Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, J. P. T. Higgins, J. Deeks, and D. G. Altman, Eds., The Cochrane Collaboration, 2011, http://www.cochrane-handbook.org. View at Google Scholar
  25. K. Thorlund, P. J. Devereaux, J. Wetterslev et al., “Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?” International Journal of Epidemiology, vol. 38, no. 1, pp. 276–286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Brok, K. Thorlund, J. Wetterslev, and C. Gluud, “Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses,” International Journal of Epidemiology, vol. 38, no. 1, pp. 287–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Thorlund, A. Anema, and E. Mills, “Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals,” Clinical Epidemiology, vol. 2, no. 1, pp. 57–66, 2010. View at Google Scholar · View at Scopus
  28. P. Herbison, J. Hay-Smith, and W. J. Gillespie, “Meta-analyses of small numbers of trials often agree with longer-term results,” Journal of Clinical Epidemiology, vol. 64, no. 2, pp. 145–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. T. A. Furukawa, C. Barbui, A. Cipriani, P. Brambilla, and N. Watanabe, “Imputing missing standard deviations in meta-analyses can provide accurate results,” Journal of Clinical Epidemiology, vol. 59, no. 1, pp. 7–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Thiessen Philbrook, N. Barrowman, and A. X. Garg, “Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal function after living kidney donation,” Journal of Clinical Epidemiology, vol. 60, no. 3, pp. 228–240, 2007. View at Publisher · View at Google Scholar · View at Scopus